Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Purpose
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Condition
- Mitral Valve Regurgitation
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Moderate to severe or severe symptomatic mitral regurgitation - Local site multidisciplinary heart team experienced in mitral valve therapies agrees that the subject is unsuitable for treatment with approved transcatheter repair or conventional mitral valve intervention
Exclusion Criteria
- prior transcatheter mitral valve procedure with device currently implanted - anatomic contraindications - prohibitive mitral annular calcification - left ventricular ejection fraction <25% - need for emergent or urgent surgery - hemodynamic instability
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Non-Randomized
- Intervention Model
- Single Group Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Primary Cohort- TMVR |
Treatment of mitral regurgitation with the Medtronic Transcatheter Mitral Valve Replacement System (TMVR) |
|
|
Experimental Mitral Annular Calcification -TMVR |
Treatment of mitral regurgitation with the Medtronic Transcatheter Mitral Valve Replacement System (TMVR) |
|
Recruiting Locations
Birmingham, Alabama 35233
Phoenix, Arizona 85018
La Jolla, California 92037
Los Angeles, California 90017
Los Angeles, California 90027
Los Angeles, California 90033
Los Angeles, California 90048
Mountain View, California 94040
San Francisco, California 94118-3100
Stanford, California 94305
Thousand Oaks, California 91360-1847
Hartford, Connecticut 06102
New Haven, Connecticut 06510
Washington D.C., District of Columbia 20010
Atlantis, Florida 33462
Fort Myers, Florida 33908
Gainesville, Florida 32605
Jacksonville, Florida 32207
Tampa, Florida 33606
Atlanta, Georgia 30308
Atlanta, Georgia 30309
Chicago, Illinois 60611
Chicago, Illinois 60612
Des Moines, Iowa 50314
Kansas City, Kansas 66160
Baltimore, Maryland 21287
Boston, Massachusetts 02114
Boston, Massachusetts 02115
Boston, Massachusetts 02215
Ann Arbor, Michigan 48109
Detroit, Michigan 48236
Grand Rapids, Michigan 49503
Minneapolis, Minnesota 55407
Minneapolis, Minnesota 55455
St Louis, Missouri 63110-1003
Missoula, Montana 59802-4008
Morristown, New Jersey 07960
Neptune City, New Jersey 07753
Manhasset, New York 11030
Mineola, New York 11501
New York, New York 10016
New York, New York 10029
New York, New York 10032
New York, New York 10467-2401
Roslyn, New York 11576
Cincinnati, Ohio 45219-2906
Cleveland, Ohio 44106
Columbus, Ohio 43210
Columbus, Ohio 43214
Oklahoma City, Oklahoma 73112
Portland, Oregon 97225
Portland, Oregon 97239
Harrisburg, Pennsylvania 17101
Pittsburgh, Pennsylvania 15213
Wynnewood, Pennsylvania 19096
Nashville, Tennessee 37203
Austin, Texas 78756
Dallas, Texas 75231
Houston, Texas 77030
Houston, Texas 77030
Houston, Texas 77030
Plano, Texas 75093
San Antonio, Texas 78229
Burlington, Vermont 05401-1473
Charlottesville, Virginia 22908
Fairfax, Virginia 22042
Norfolk, Virginia 23507-1904
Roanoke, Virginia 24014
Seattle, Washington 98195
Spokane, Washington 99204
Milwaukee, Wisconsin 53215
More Details
- NCT ID
- NCT03242642
- Status
- Recruiting
- Sponsor
- Medtronic Cardiovascular